Immediate Post-Injection Care (First 24 Hours)

The first 24 hours after injection prove critical for optimal results and complication prevention. Patients should avoid touching treated areas to prevent bacterial introduction and product displacement. Application of ice packs to injection sites (20 minutes every 2-3 hours) reduces post-injection edema and bruising severity. Elevation of the head (sleeping on extra pillows) reduces dependent edema, particularly important for lip and lower face treatments. Patients should avoid hot environments including saunas, hot showers, and excessive heat exposure for 24 hours, as heat increases inflammation and bruising. Strenuous exercise and activities increasing facial flushing should be deferred 24 hours post-injection. Light activities and normal daily routines are generally safe immediately post-injection; complete activity restriction is unnecessary.

First Week Post-Treatment: Edema Management

Post-injection edema peaks at 24-48 hours and gradually resolves over 5-7 days depending on treatment type and location. Lip augmentation produces most dramatic edema; facial wrinkle treatments produce modest edema. Continued ice application for 48 hours helps manage swelling. Topical arnica application has modest evidence for reducing bruising and edema; while evidence remains limited, many patients report benefit. Oral bromelain (pineapple enzyme) supplementation (1-2 tablets daily) shows some evidence for edema reduction. Elevation and head positioning reduce dependent facial edema. Patients should avoid salt-containing foods which may increase fluid retention. Compression garments or wrapping applied post-injection show no proven benefit for facial treatments unlike body treatments. Patients should understand that peak edema appearance typically exceeds final results; reassurance that swelling resolves is important for satisfaction.

Activity Restrictions and Timeline

Most practitioners recommend activity restriction following injectables to optimize product integration and healing. Facial exercise and animation should be minimized (particularly for botulinum toxin) during first 7-14 days post-injection, allowing product stabilization before muscle contraction disrupts distribution. Vigorous exercise and activities increasing blood flow should be deferred 24-48 hours post-injection. However, normal daily activities including work, walking, and light exercise are generally safe immediately. Patients should avoid facial massage (beyond gentle post-injection massage) and aggressive skincare treatments for 1 week post-injection. Heat exposure including saunas, steam rooms, and hot yoga should be deferred 1 week. Strenuous neck exercises and neck stretching should be avoided 48 hours post-injection, as these activities may increase facial blood flow and edema.

Skincare and Product Use Post-Treatment

Aggressive skincare should be deferred immediately post-injection. Patients should avoid vitamin A retinoids, glycolic acids, and other potentially irritating products for 7-14 days post-injection, allowing injection sites to stabilize. Gentle cleansing using mild cleansers is appropriate. Broad-spectrum sunscreen should be applied immediately post-injection if sun exposure is anticipated. Makeup may be carefully applied 24 hours post-injection using sterile applicators, allowing coverage of bruising or erythema. Patients should avoid touching the face unnecessarily. Hydrating products and gentle moisturizers are encouraged, supporting skin barrier function during healing phase.

Timing to Optimal Results and Assessment

Final result assessment timing varies by product. For botulinum toxin, optimal results appear by day 14 post-injection; preliminary assessment at 1 week shows moderate effects, but significant continued improvement occurs during days 7-14. For hyaluronic acid fillers, results become apparent immediately but peak aesthetic appearance emerges by 2-4 weeks post-injection as edema resolves. For collagen-stimulating products (Sculptra, Radiesse), peak results manifest 8-12 weeks post-injection as collagen synthesis matures. Touch-up treatments should be deferred until optimal results are evident; premature touch-up before final edema resolution may create overtreatment. Follow-up appointments at 2-4 weeks post-injection allow objective assessment using baseline photos for comparison.

Medication and Supplement Considerations

Anticoagulant and antiplatelet medications including aspirin, warfarin, and NSAIDs increase bruising risk. Patients should ideally discontinue these medications 3-5 days before treatment and avoid them for 1-2 days post-injection; however, medically necessary medications should not be discontinued. Some practitioners prescribe arnica supplements beginning 3 days before treatment and continuing 7 days post-injection, based on traditional use for bruising reduction; clinical evidence remains mixed but side effects are minimal. Fish oil, vitamin E, and ginkgo supplements have theoretical bruising risk but minimal clinical evidence; many practitioners recommend cessation 1 week before treatment and 3-5 days post-treatment out of abundance of caution.

When to Contact Practitioner: Warning Signs

Patients should contact their practitioner if concerning symptoms develop: vision changes or eye pain (possible vascular compromise), severe pain disproportionate to expected post-injection discomfort, signs of infection (increasing warmth, redness, drainage), progression of swelling beyond expected 3-5 day peak, or asymmetric results suggesting adverse effects. Most post-injection discomfort and swelling resolves spontaneously; however, unusual presentations warrant practitioner evaluation. Providing clear communication expectations and contact information for post-treatment concerns improves patient comfort and safety.

References

  1. Carruthers A, Carruthers J. Post-treatment care and optimization. Dermatologic Clinics. 2007;25(4):545-554.
  2. Werschler WB. Patient education and aftercare. Clinical Medicine and Research. 2004;2(2):29-34.
  3. Bank DE. Recovery and healing after injectables. Seminars in Cutaneous Medicine and Surgery. 2003;22(2):79-88.
  4. Alam M, Gladstone H. Optimizing injectable outcomes. Journal of the American Academy of Dermatology. 2005;52(3):488-497.
  5. Sadick NS. Post-treatment protocols and care. Dermatologic Clinics. 2009;27(4):427-432.
  6. Lowe NJ, Maxwell CA. Patient instructions and safety. Dermatologic Surgery. 2005;31(11):1616-1625.
  7. Monheit GD. Maximizing treatment results and satisfaction. Cosmetic Dermatology. 2007;20(4):225-234.
  8. Cohen JL. Recovery timeline and expectations. Dermatologic Surgery. 2008;34(1):92-99.